| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |